PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
21800306-6	2012	However, 33% of PPG(+) neurons contain neurokinin-1 receptor (NK1R) in the rVRG (126 +- 12; n = 12), accounting for ~28% of all NK1R(+) neurons in the region.	ppg	16-19	tachykinin receptor 1	Rattus norvegicus	39-60
21800306-6	2012	However, 33% of PPG(+) neurons contain neurokinin-1 receptor (NK1R) in the rVRG (126 +- 12; n = 12), accounting for ~28% of all NK1R(+) neurons in the region.	ppg	16-19	tachykinin receptor 1	Rattus norvegicus	62-66
21651690-7	2011	The GLP-1 group was associated with a greater reduction in PPG than the insulin group.	ppg	59-62	glucagon like peptide 1 receptor	Homo sapiens	4-9
22870268-10	2012	CSE inhibition by PPG and BCA reduced this effect in aortas from rats but not from mice.	ppg	18-21	cystathionine gamma-lyase	Rattus norvegicus	0-3
21131483-7	2011	The dilation to L-cysteine was blocked by the CSE inhibitor d,l-propargylglycine (PPG, 10 mM) but was unaffected by the CBS inhibitor amino-oxyacetate (AOA, 1 mM).	ppg	82-85	cystathionine gamma-lyase	Sus scrofa	46-49
21830440-5	2011	RESULTS: Patients in the PPG-nCBP group had a higher body mass index than patients in the PPG-CBP group (23.9 vs. 22.3 kg/m2; p=0.004), as well as a longer operation time (249.3 vs. 227.0 min; p=0.010).	ppg	25-28	nuclear cap binding protein subunit 1	Homo sapiens	29-33
21830440-5	2011	RESULTS: Patients in the PPG-nCBP group had a higher body mass index than patients in the PPG-CBP group (23.9 vs. 22.3 kg/m2; p=0.004), as well as a longer operation time (249.3 vs. 227.0 min; p=0.010).	ppg	25-28	CREB binding protein	Homo sapiens	30-33
20702417-7	2010	pPG-induced silkworm death was delayed by injecting melanization-inhibiting reagents (a serine protease inhibitor and 1-phenyl-2-thiourea), antioxidants (N-acetyl-l-cysteine, glutathione, and catalase), and a caspase inhibitor (Ac-DEVD-CHO).	ppg	0-3	catalase	Bombyx mori	192-200
22255218-6	2011	These preliminary results suggest that a PPG sensor may be a suitable method for evaluating the perfusion of free flap.	ppg	41-44	arachidonate 5-lipoxygenase activating protein	Homo sapiens	114-118
19766903-5	2009	The aim of this study was to determine a relationship between SUR-1 [exon 16 (-3C/T), exon 31 (Arg1273Arg; AGG-->AGA) and exon 33 (S1369A)] and KCNJ11 (E23K) polymorphisms and the following parameters of metabolic control in T2D: fasting plasma glucose (FPG), postprandial glucose (PPG) and HbA1c in Caucasian T2D of European origin.	ppg	285-288	ATP binding cassette subfamily C member 8	Homo sapiens	62-67
20142152-10	2010	These results suggest that the combination of DAP and PTTV could be better alternative for sleep apnea screening using PPG with the added benefit of its low cost and simplicity.	ppg	119-122	death associated protein	Homo sapiens	46-49
20088941-7	2010	Multiple regression analyses in the acarbose group revealed that PPG was the only significant predictor of 11-dehydro-TXB(2) urinary excretion rate (beta = 0.39, P = 0.002) and MAGE the only predictor of 8-iso-PGF(2alpha) urinary excretion rate (beta = 0.42, P = 0.001).	ppg	65-68	placental growth factor	Homo sapiens	210-213
21155215-15	2009	Pre-administration of PPG exacerbated the injuries induced by LPS, increased PMN and protein content in BALF, the plasma NO level, lung iNOS activity and its protein expression, but there was no prominent variation in CO level, HO activity and HO-1 protein expression compared with those of LPS group.	ppg	22-25	nitric oxide synthase 2	Rattus norvegicus	136-140
21155215-15	2009	Pre-administration of PPG exacerbated the injuries induced by LPS, increased PMN and protein content in BALF, the plasma NO level, lung iNOS activity and its protein expression, but there was no prominent variation in CO level, HO activity and HO-1 protein expression compared with those of LPS group.	ppg	22-25	heme oxygenase 1	Rattus norvegicus	244-248
19369363-7	2009	Furthermore, the selective mGluR4 agonist ACPT-III and mGluR8 agonist PPG were effective at reducing the field potential, whereas agonists selective for mGluR6 and 7 were not.	ppg	70-73	glutamate receptor, ionotropic, AMPA4 (alpha 4)	Mus musculus	27-33
19369363-7	2009	Furthermore, the selective mGluR4 agonist ACPT-III and mGluR8 agonist PPG were effective at reducing the field potential, whereas agonists selective for mGluR6 and 7 were not.	ppg	70-73	glutamate receptor, metabotropic 8	Mus musculus	55-61
19077774-4	2009	Several antidiabetic agents that specifically target PPG are currently available, including glinides, glucagon-like peptide-1 mimetics, dipeptidyl peptidase-4 inhibitors, and rapid-acting insulin analogs.	ppg	53-56	glucagon	Homo sapiens	102-125
19234054-9	2009	However, pulmonary artery MMP-13 and TIMP-1 expressions decreased significantly in rats of shunt+PPG group (P<0.01).	ppg	97-100	matrix metallopeptidase 13	Rattus norvegicus	26-32
19234054-9	2009	However, pulmonary artery MMP-13 and TIMP-1 expressions decreased significantly in rats of shunt+PPG group (P<0.01).	ppg	97-100	TIMP metallopeptidase inhibitor 1	Rattus norvegicus	37-43
19077774-4	2009	Several antidiabetic agents that specifically target PPG are currently available, including glinides, glucagon-like peptide-1 mimetics, dipeptidyl peptidase-4 inhibitors, and rapid-acting insulin analogs.	ppg	53-56	dipeptidyl peptidase 4	Homo sapiens	136-158
18558402-7	2008	Additionally, the effect of PPG on reactive oxygen species (ROS) production and induction of IL-10, IL-12 and IFN-gamma secretion by human peripheral blood mononuclear cells (PBMCs) isolated from healthy individuals was investigated.	ppg	28-31	interleukin 10	Homo sapiens	93-98
18558402-7	2008	Additionally, the effect of PPG on reactive oxygen species (ROS) production and induction of IL-10, IL-12 and IFN-gamma secretion by human peripheral blood mononuclear cells (PBMCs) isolated from healthy individuals was investigated.	ppg	28-31	interferon gamma	Homo sapiens	110-119
18558402-8	2008	The water-soluble secreted form of PPG at a concentration of 1 microg glycan/ml seems to be a potent inducer of ROS and IL-10 and to a lesser extent of IFN-gamma and IL-12.	ppg	35-38	interleukin 10	Homo sapiens	120-125
18558402-8	2008	The water-soluble secreted form of PPG at a concentration of 1 microg glycan/ml seems to be a potent inducer of ROS and IL-10 and to a lesser extent of IFN-gamma and IL-12.	ppg	35-38	interferon gamma	Homo sapiens	152-161
18248901-8	2008	Furthermore, PPG pretreatment attenuated the induction of c-Fos in spinal laminae I-II following injection of 5% formalin.	ppg	13-16	Fos proto-oncogene, AP-1 transcription factor subunit	Homo sapiens	58-63
16919548-2	2006	After a meal, the rise in postprandial glucose (PPG) is controlled by the rapid pancreatic release of insulin, stimulated by both glucose and the intestinal production of the incretins glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1.	ppg	48-51	insulin	Homo sapiens	102-109
18667139-5	2007	Subsequently, a progressive loss of first-phase insulin response occurs, which is manifested by progressively increasing postprandial glucose (PPG) levels.	ppg	143-146	insulin	Homo sapiens	48-55
17375403-3	2006	Alpha-glucosidase inhibitors can reduce PPG by a mean 0.50 g/l, no matter what the insulin resistance or insulinopenia status or the other diabetes treatments already in use.	ppg	40-43	sucrase-isomaltase	Homo sapiens	0-17
16919548-2	2006	After a meal, the rise in postprandial glucose (PPG) is controlled by the rapid pancreatic release of insulin, stimulated by both glucose and the intestinal production of the incretins glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1.	ppg	48-51	glucagon	Homo sapiens	234-257
16919548-11	2006	The development of glucagon-like peptide 1 agonists such as exendin and dipeptidyl peptidase IV inhibitors such as vildagliptin offers a new approach to suppression of PPG elevation.	ppg	168-171	glucagon	Homo sapiens	19-42
16526817-8	2006	Treating PPG with glinides improves IMT as well as interleukin-6 and C-reactive protein levels, while treating PPG with rapid-acting insulin analogues is also associated with improvements in endothelial dysfunction.	ppg	9-12	interleukin 6	Homo sapiens	51-64
16526817-8	2006	Treating PPG with glinides improves IMT as well as interleukin-6 and C-reactive protein levels, while treating PPG with rapid-acting insulin analogues is also associated with improvements in endothelial dysfunction.	ppg	9-12	C-reactive protein	Homo sapiens	69-87
16526817-8	2006	Treating PPG with glinides improves IMT as well as interleukin-6 and C-reactive protein levels, while treating PPG with rapid-acting insulin analogues is also associated with improvements in endothelial dysfunction.	ppg	111-114	insulin	Homo sapiens	133-140
16000308-3	2005	The phage display-derived recognition motif for CD2BP2-GYF is PPG(W/F/Y/M/L).	ppg	62-65	CD2 cytoplasmic tail binding protein 2	Homo sapiens	48-54
14970889-4	2004	Meanwhile, the activities of CSE in pulmonary tissue in hypoxic, hypoxic + L-NAME and control groups were detected, respectively, and expressions of NOS in pulmonary arteries in hypoxic, hypoxic + PPG and control groups were also detected by immunohistochemistry technique.	ppg	197-200	cystathionine gamma-lyase	Rattus norvegicus	29-32
16145866-9	2005	Only marginally statistically significant influence of p53 expression was found on patient survival between MPG and PPG.	ppg	116-119	tumor protein p53	Homo sapiens	55-58
14606987-8	2003	The insulin sensitizer metformin, on the other hand, does not affect PPG levels, whereas the alpha-glucosidase inhibitors, in the presence of a high-carbohydrate diet, can effectively lower PPG.	ppg	190-193	sucrase-isomaltase	Homo sapiens	93-110
12689550-9	2003	In DM2 patients, a bad control was observed in 82.1% (CI 95%, 77.9-86.3) of them according to BG, in 88.4% (85.1-91.7) according to PPG and in 18.8% (14.3-23.3) according to A1C.	ppg	132-135	immunoglobulin heavy diversity 1-14 (non-functional)	Homo sapiens	3-6
12376193-5	2002	For example, AIDA (50 mM; mGLUR(1) antagonist) blocked the effects of EC(50) concentrations of 3,5-DHPG, and PPG.	ppg	109-112	axin interactor, dorsalization associated	Rattus norvegicus	13-17
12376193-5	2002	For example, AIDA (50 mM; mGLUR(1) antagonist) blocked the effects of EC(50) concentrations of 3,5-DHPG, and PPG.	ppg	109-112	glutamate receptor, ionotropic, AMPA1 (alpha 1)	Mus musculus	26-34
12376193-8	2002	CPPG (80 mM) and MSOP (125 mM), mGLUR(4) antagonists, blocked the effects of 3,5-DHPG, PPG and L-AP(4.)	ppg	1-4	glutamate receptor, ionotropic, AMPA4 (alpha 4)	Mus musculus	32-40
9293701-4	1997	The smallest (0.15 micron diameter) PPG was the least dense granule, had a unique peroxidase/beta-glucuronidase ratio, reacted intensely for vicinal glycols, resisted ionophore degranulation and was not consumed in giant granule formation in Chediak-Higashi Syndrome.	ppg	36-39	glucuronidase beta	Homo sapiens	93-111
11198928-3	2000	Phosphodiester pyrrazolopyrimidine dG (PPG)-modified TFO complementary to the polypurine-polypyrimidine region of the mdr1 gene were synthesized and labeled with 125I-dCTP at the C5 position of two cytosines by the primer extension method.	ppg	39-42	ATP binding cassette subfamily B member 1	Homo sapiens	118-122
10378794-2	1999	In this study, we undertook to clarify the relationship between P-glycoprotein positivity (%PPG) and doxorubicin binding ability (%DB) in human osteosarcomas in order to determine which is a more sensitive index of histologic response to chemotherapy.	ppg	92-95	ATP binding cassette subfamily B member 1	Homo sapiens	64-78
11374906-3	2001	Unlike Esx1, ESXR1 contains 12 repeats of a unique nine amino acid motif, PPMAP(V/L)PPG, located C-terminal to the homeodomain.	ppg	84-87	ESX homeobox 1	Homo sapiens	13-18
34772419-6	2021	RESULTS: After nateglinide treatment for 8 consecutive weeks, patients with at least one C allele of PPARD rs2016520 showed a smaller decrease in post plasma glucose (PPG), homeostasis model assessment for beta cell function (HOMA-B) than those with the TT genotype did (P < 0.05).	ppg	167-170	peroxisome proliferator activated receptor delta	Homo sapiens	101-106
1306602-8	1992	The fasting and postprandial serum gastrin levels were high in one patient with recurrence, whose antrum was preserved as long as 3 cm proximal to the pyloric ring; this was longer than that described in our original method of PPG.	ppg	227-230	gastrin	Homo sapiens	35-42
33776458-8	2021	Conclusion: The analysis indicates that the supplementation of BOT with a single daily injection of prandial insulin is safe and effective for reducing HbA1c and PPG levels in patients with a high BeAM value (more than 50 mg/dl).	ppg	162-165	insulin	Homo sapiens	109-116
34779492-9	2022	PPG (a CSE inhibitor) abolished the beneficial effects of SKF38393.	ppg	0-3	cystathionase (cystathionine gamma-lyase)	Mus musculus	7-10
34220720-10	2021	In both groups, the reduction in PPG was accompanied by a two-three-fold increase in GLP-1 and delayed gastric emptying.	ppg	33-36	glucagon	Homo sapiens	85-90
34220720-14	2021	Conclusion: Pre-meal ingestion of a novel, ready-to-drink WP shot containing just 15 g of dietary protein reduced PPG in lean and centrally obese males.	ppg	114-117	short stature homeobox 2	Homo sapiens	61-65
34220720-15	2021	However, an attenuated GLP-1 response to mealtime WP and increased incretin degradation might impact the efficacy of nutritional strategies utilising the actions of GLP-1 to regulate PPG in centrally obese populations.	ppg	183-186	glucagon	Homo sapiens	23-28
34220720-15	2021	However, an attenuated GLP-1 response to mealtime WP and increased incretin degradation might impact the efficacy of nutritional strategies utilising the actions of GLP-1 to regulate PPG in centrally obese populations.	ppg	183-186	glucagon	Homo sapiens	165-170
35598134-8	2022	About 73.5% of the respondents believed controlling fasting plasma glucose (FPG) level alone would not adequately control postprandial plasma glucose (PPG) level, and 93.0% of them preferred an insulin therapy at the initiation that controls both FPG and PPG levels.	ppg	255-258	insulin	Homo sapiens	194-201
34150441-3	2021	The aim of this study was to define the differences in the efficacy of these two insulin analogues on PPG.	ppg	102-105	insulin	Homo sapiens	81-88
35593434-8	2022	Indeed, in pivotal phase 3 trials, URLi was superior to Lispro for PPG control both at 1 hour and 2 hours after a meal in type 1 and type 2 diabetes with multiple daily injections and in type 1 diabetes with continuous subcutaneous insulin infusion.	ppg	67-70	insulin	Homo sapiens	232-239
35598134-9	2022	CONCLUSION: Limited consultation time, high-carbohydrate diet, and a need for choosing insulin regimens that provide control for both PPG and FPG levels are some ground realities of DM management in India.	ppg	134-137	insulin	Homo sapiens	87-94
35226992-17	2022	PPG (a CSE inhibitor) abolished the beneficial effect of SKF38393.	ppg	0-3	cystathionine gamma-lyase	Homo sapiens	7-10
35509763-2	2022	This study aims to compare the serum PRL levels between type 2 diabetes mellitus (T2DM) patients and normoglycaemic volunteers and correlate the serum PRL level with fasting plasma glucose (FPG), postprandial plasma glucose (PPG), glycated haemoglobin (HbA1c) levels, and the lipid profile in the study population.	ppg	225-228	prolactin	Homo sapiens	151-154
33460657-4	2021	Thioflavin-T (ThT) fluorescence assays showed that the binding of EA or PPG could effectively inhibit the nucleation and elongation of PrP fibrilization and reduce the amount of PrP fibrils generated.	ppg	72-75	prion protein	Homo sapiens	135-138
35044568-2	2022	The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naive or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials.	ppg	37-40	insulin	Homo sapiens	122-129
35044568-2	2022	The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naive or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials.	ppg	37-40	insulin	Homo sapiens	139-146
35044568-2	2022	The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naive or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials.	ppg	37-40	insulin	Homo sapiens	177-184
35044568-2	2022	The aim of this study was to compare PPG increments in Asian versus non-Asian adults with type 2 diabetes (T2D), who were insulin-naive or insulin-experienced, from the phase 3 insulin degludec/insulin aspart (IDegAsp) clinical trials.	ppg	37-40	insulin	Homo sapiens	194-201
33730337-1	2021	INTRODUCTION: Basal-bolus (BB) and premixed insulin regimens may lower fasting plasma glucose (FPG) and postprandial plasma glucose (PPG), but are complex to use and associated with weight gain and hypoglycaemia.	ppg	133-136	insulin	Homo sapiens	44-51
33658478-2	2021	We performed a systematic review and meta-analysis to quantify effects of alpha-glucosidase-inhibiting (AGI) drugs on acute PPG and PPI responses.	ppg	124-127	sucrase-isomaltase	Homo sapiens	74-91
33460657-4	2021	Thioflavin-T (ThT) fluorescence assays showed that the binding of EA or PPG could effectively inhibit the nucleation and elongation of PrP fibrilization and reduce the amount of PrP fibrils generated.	ppg	72-75	prion protein	Homo sapiens	178-181
33460657-6	2021	Circular dichroism (CD) measurements suggested that EA- or PPG-bound PrP could preserve a higher content of alpha-helical structures than beta-sheet-rich PrP fibrils.	ppg	59-62	prion protein	Homo sapiens	69-72
33644113-11	2020	The membrane translocation of nPKCdelta and the expression of VCAM-1 in UAAS group was higher than sham group, L-cys or NaHS injection could suppress the membrane translocation of nPKCdelta and the expression of VCAM-1, but PPG treatment resulted in more membrane translocation of nPKCdelta and the expression of VCAM-1 (P<0.05, n=6 per group).	ppg	224-227	protein kinase C delta	Homo sapiens	30-39
33644113-11	2020	The membrane translocation of nPKCdelta and the expression of VCAM-1 in UAAS group was higher than sham group, L-cys or NaHS injection could suppress the membrane translocation of nPKCdelta and the expression of VCAM-1, but PPG treatment resulted in more membrane translocation of nPKCdelta and the expression of VCAM-1 (P<0.05, n=6 per group).	ppg	224-227	vascular cell adhesion molecule 1	Homo sapiens	212-218
33644113-11	2020	The membrane translocation of nPKCdelta and the expression of VCAM-1 in UAAS group was higher than sham group, L-cys or NaHS injection could suppress the membrane translocation of nPKCdelta and the expression of VCAM-1, but PPG treatment resulted in more membrane translocation of nPKCdelta and the expression of VCAM-1 (P<0.05, n=6 per group).	ppg	224-227	vascular cell adhesion molecule 1	Homo sapiens	212-218
33644113-12	2020	Akt phosphorylation in UAAS group was lower than sham group, and L-cys or NaHS injection could suppress the degradation of Akt phosphorylation, but PPG treatment resulted in more decrease in the Akt phosphorylation (P<0.05, n=6 per group).	ppg	148-151	AKT serine/threonine kinase 1	Homo sapiens	0-3
33644113-12	2020	Akt phosphorylation in UAAS group was lower than sham group, and L-cys or NaHS injection could suppress the degradation of Akt phosphorylation, but PPG treatment resulted in more decrease in the Akt phosphorylation (P<0.05, n=6 per group).	ppg	148-151	AKT serine/threonine kinase 1	Homo sapiens	123-126
33644113-12	2020	Akt phosphorylation in UAAS group was lower than sham group, and L-cys or NaHS injection could suppress the degradation of Akt phosphorylation, but PPG treatment resulted in more decrease in the Akt phosphorylation (P<0.05, n=6 per group).	ppg	148-151	AKT serine/threonine kinase 1	Homo sapiens	123-126
32277270-11	2021	Changes in acute PPG were significantly associated with changes in fasting plasma glucose (FPG) [per 10% change in PPG: beta = 0.085 (95% CI 0.003, 0.167), k = 14], but not with fasting insulin [beta = 1.20 (95% CI - 0.32, 2.71), k = 12].	ppg	17-20	insulin	Homo sapiens	186-193
32436323-6	2020	Recently, fixed-ratio combinations (FRCs) of BI and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown efficacy in reducing both FPG and PPG with a single injection and without increased risk of hypoglycaemia or weight gain.	ppg	151-154	glucagon like peptide 1 receptor	Homo sapiens	52-84
32641052-7	2020	However, PPG had the benefits of lower incidence of anastomosis leakage, early dumping syndrome, gastritis and bile reflux, and better recovery of total protein, albumin, hemoglobin, and weight.	ppg	9-12	albumin	Homo sapiens	162-169
33786271-1	2021	Background: In general, basal insulin targets fasting plasma glucose (FPG) levels, and prandial insulin targets postprandial glucose (PPG) levels.	ppg	134-137	insulin	Homo sapiens	96-103
33786271-2	2021	However, the effects of basal insulin on PPG levels are controversial.	ppg	41-44	insulin	Homo sapiens	30-37
33318871-8	2021	PPG inhibited expression of PPARdelta and SOCS3, stimulated the phosphorylation of STAT3, increased inflammatory molecules production and proliferation rate of VSMCs which could all be corrected by NaHS supply.	ppg	0-3	peroxisome proliferator activator receptor delta	Mus musculus	28-37
33318871-8	2021	PPG inhibited expression of PPARdelta and SOCS3, stimulated the phosphorylation of STAT3, increased inflammatory molecules production and proliferation rate of VSMCs which could all be corrected by NaHS supply.	ppg	0-3	suppressor of cytokine signaling 3	Mus musculus	42-47
33318871-8	2021	PPG inhibited expression of PPARdelta and SOCS3, stimulated the phosphorylation of STAT3, increased inflammatory molecules production and proliferation rate of VSMCs which could all be corrected by NaHS supply.	ppg	0-3	signal transducer and activator of transcription 3	Mus musculus	83-88
30036087-4	2019	Inhibition of both cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS), 2 major enzymes for endogenous H2S production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla.	ppg	160-163	cystathionase (cystathionine gamma-lyase)	Mus musculus	19-44
31963730-4	2020	A PARP-1 enzyme inhibition assay and PARylation experiment showed that the inhibitory activity of the prodrug was reduced 380 times and more than 658 times, respectively, which proved that the prodrug"s expected activity was lost after PPG protection.	ppg	236-239	poly(ADP-ribose) polymerase 1	Homo sapiens	2-8
31226281-3	2019	OBJECTIVES: To evaluate how often patients on insulin therapy measure PPG and modify insulin doses accordantly.	ppg	70-73	insulin	Homo sapiens	46-53
30466191-4	2019	RESULTS: A statistically significant treatment difference in favour of fast-acting insulin aspart vs. insulin aspart was observed for the change in PPG increment at all post-meal time points (from 1 to 4 h) for those in the > 20 units bolus insulin subgroup.	ppg	148-151	insulin	Homo sapiens	83-90
30466191-4	2019	RESULTS: A statistically significant treatment difference in favour of fast-acting insulin aspart vs. insulin aspart was observed for the change in PPG increment at all post-meal time points (from 1 to 4 h) for those in the > 20 units bolus insulin subgroup.	ppg	148-151	insulin	Homo sapiens	102-109
30466191-4	2019	RESULTS: A statistically significant treatment difference in favour of fast-acting insulin aspart vs. insulin aspart was observed for the change in PPG increment at all post-meal time points (from 1 to 4 h) for those in the > 20 units bolus insulin subgroup.	ppg	148-151	insulin	Homo sapiens	102-109
30466191-6	2019	CONCLUSION: Fast-acting insulin aspart may hold promise as a more effective treatment compared with insulin aspart for controlling PPG in people with insulin-resistant Type 2 diabetes.	ppg	131-134	insulin	Homo sapiens	24-31
30036087-4	2019	Inhibition of both cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS), 2 major enzymes for endogenous H2S production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla.	ppg	160-163	cystathionase (cystathionine gamma-lyase)	Mus musculus	46-49
30036087-4	2019	Inhibition of both cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS), 2 major enzymes for endogenous H2S production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla.	ppg	160-163	cystathionine beta-synthase	Mus musculus	55-82
30036087-4	2019	Inhibition of both cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (CBS), 2 major enzymes for endogenous H2S production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla.	ppg	160-163	cystathionine beta-synthase	Mus musculus	84-87
30036087-5	2019	Mice treated with both PPG and AOAA developed a urine concentration defect in response to dehydration that was accompanied by reduced AQP-2 protein expression.	ppg	23-26	aquaporin 2	Mus musculus	134-139
32142871-7	2020	And the results showed that more pPG-612-AHA1-CK6-VP2/L.	ppg	33-36	activator of HSP90 ATPase activity 1	Homo sapiens	41-45
32821480-9	2020	The ability to diagnose PPG using these GCL/IPL parameters was statistically higher than for total or superior and inferior hemiretinal GCL/IPL thicknesses.	ppg	24-27	germ cell-less 2, spermatogenesis associated	Homo sapiens	40-43
32821480-9	2020	The ability to diagnose PPG using these GCL/IPL parameters was statistically higher than for total or superior and inferior hemiretinal GCL/IPL thicknesses.	ppg	24-27	pleckstrin homology like domain family A member 2	Homo sapiens	44-47
29493118-1	2018	AIM: To investigate the mechanisms behind the lower postprandial glucose (PPG) concentrations achieved with fast-acting insulin aspart (faster aspart) than with insulin aspart (IAsp).	ppg	74-77	insulin	Homo sapiens	161-168
30058059-9	2018	The treatment factors influencing the choice of a DPP-4 inhibitor were glycated hemoglobin (HbA1c) and postprandial glucose (PPG) lowering effect, frequency of administration, effect on glucagon, and ease of use in patients with renal or liver impairment.	ppg	125-128	dipeptidyl peptidase 4	Homo sapiens	50-55
30058059-11	2018	The patient characteristics for the choice of DPP-4 inhibitors among diabetologists were predominantly PPG, concern about hypoglycemia, diabetes complications, and adherence to diet and exercise.	ppg	103-106	dipeptidyl peptidase 4	Homo sapiens	46-51
29696567-10	2018	The key patient characteristics driving the choice of DPP-4is or metformin as the first-line OAD by physicians were similar to those that influenced the treatment intensification decision (DPP-4is: PPG and renal function; metformin: age, BMI, insulin resistance, and renal function).	ppg	198-201	dipeptidyl peptidase 4	Homo sapiens	189-194
29916741-4	2018	Thus, a dual SGLT1 and SGLT2 inhibition (compared with selective SGLT2 inhibition) could result in lower PPG and robust A1c reduction even in patients with reduced kidney function.	ppg	105-108	solute carrier family 5 member 1	Homo sapiens	13-18
29916741-4	2018	Thus, a dual SGLT1 and SGLT2 inhibition (compared with selective SGLT2 inhibition) could result in lower PPG and robust A1c reduction even in patients with reduced kidney function.	ppg	105-108	solute carrier family 5 member 2	Homo sapiens	23-28
29916741-4	2018	Thus, a dual SGLT1 and SGLT2 inhibition (compared with selective SGLT2 inhibition) could result in lower PPG and robust A1c reduction even in patients with reduced kidney function.	ppg	105-108	solute carrier family 5 member 2	Homo sapiens	65-70
29319536-6	2018	The best estimation model based on the combination of PPG and PPT could achieve a decrease (GAM &amp; GSD) of 0.81  +-  0.95 mmHg in SBP and 0.75  +-  0.54 mmHg in DBP in comparison to the PPT-based methods.	ppg	54-57	tachykinin precursor 1	Homo sapiens	189-192
29493118-1	2018	AIM: To investigate the mechanisms behind the lower postprandial glucose (PPG) concentrations achieved with fast-acting insulin aspart (faster aspart) than with insulin aspart (IAsp).	ppg	74-77	insulin	Homo sapiens	120-127
29955237-7	2018	CSE inhibitor PPG drastically inhibited TFR-evoked vasodilatation resistant to L-NAME and Indo in endothelium-intact rat CBA.	ppg	14-17	transferrin receptor	Rattus norvegicus	40-43
28408352-11	2017	These results suggest that Hdh-GnRH mRNA expression profiles in the BG and possibly the PPG are tightly correlated with abalone reproductive activities.	ppg	88-91	gonadotropin releasing hormone 1	Homo sapiens	31-35
28117542-13	2017	CONCLUSION: Applying an additional dose of insulin in dual wave bolus for high-protein mixed meal improved PPG.	ppg	107-110	insulin	Homo sapiens	43-50
27986406-12	2017	CONCLUSIONS: Lixisenatide in combination with basal insulin was shown to be an effective treatment strategy for patients with type 2 diabetes, controlling HbA1c levels by reduction of PPG excursions during the whole day.	ppg	184-187	insulin	Homo sapiens	52-59
29032696-6	2017	Appropriately timed exposure of the liver to insulin is critical in suppressing hepatic glucose output (and therefore PPG levels) after a meal.	ppg	118-121	insulin	Homo sapiens	45-52
26413295-13	2015	In all the studies that estimated the relative contribution FPG and PPG to the overall hyperglycemia, decreases in PPG was accounted for greater decrease in HbA1c compared with decreases in FPG value.	ppg	115-118	hemoglobin subunit alpha 1	Homo sapiens	157-161
26827116-10	2016	For exenatide BID, reductions in PPG excursions for all meals were significantly greater in Asians (P&lt;0.0001 vs Whites), whereas only post-breakfast and post-lunch excursions were significantly greater in Asians for exenatide QW (P=0.0009 and P=0.0189 vs Whites, respectively).	ppg	33-36	BH3 interacting domain death agonist	Homo sapiens	14-17
26827116-12	2016	CONCLUSIONS: Exenatide BID and QW improved glycemic control, including PPG, in Asian and White patients with T2DM.	ppg	71-74	BH3 interacting domain death agonist	Homo sapiens	23-26
26827116-13	2016	With exenatide BID, Asian patients exhibited significantly greater reductions in HbA1c and PPG than White patients.	ppg	91-94	BH3 interacting domain death agonist	Homo sapiens	15-18
27043162-5	2016	The goal of this review is to summarize the effects of albiglutide on PPG in four phase 2 trials and to describe the PPG-lowering effects of the GLP-1 RAs.	ppg	117-120	glucagon like peptide 1 receptor	Homo sapiens	145-150
27136525-2	2016	Highly potent VEGFR-2 inhibitors 1 and 3 were caged by introduction of a photoremovable protecting group (PPG) to yield the caged prodrugs 4 and 5.	ppg	106-109	kinase insert domain receptor	Homo sapiens	14-21
24793048-6	2015	Pre-incubation with the cystathionine gamma-lyase inhibitor, D,L-propargylglycine (PPG), resulted in a paradoxical augmentation of shear stress-mediated vasodilation.	ppg	83-86	cystathionase (cystathionine gamma-lyase)	Mus musculus	24-49
25945746-8	2015	PPG decreased creatinine, H2S, IL-10, and TNF-alpha levels, but this effect was reversed by NaHS administration.	ppg	0-3	interleukin 10	Rattus norvegicus	26-36
25945746-8	2015	PPG decreased creatinine, H2S, IL-10, and TNF-alpha levels, but this effect was reversed by NaHS administration.	ppg	0-3	tumor necrosis factor	Rattus norvegicus	42-51
28239260-2	2015	In this work, the extraction ability for bovine serum albumin (BSA) of aqueous biphasic systems (ABS) formed by polypropylene glycol 400 (PPG 400) and several GB-ILs was evaluated.	ppg	138-141	albumin	Homo sapiens	48-61
26053860-3	2015	Identification and specific labeling of PPG was achieved through cell type-specific RNAi-mediated knockdown (KD) of a glial marker, Glutamine Synthetase 2 (GS2).	ppg	40-43	Glutamine synthetase 2	Drosophila melanogaster	132-154
26053860-3	2015	Identification and specific labeling of PPG was achieved through cell type-specific RNAi-mediated knockdown (KD) of a glial marker, Glutamine Synthetase 2 (GS2).	ppg	40-43	Glutamine synthetase 2	Drosophila melanogaster	156-159
25881041-10	2015	In addition, both MMPIP and PPG acted as inverse agonists at mGluR7, and agonists at mGluR8.	ppg	28-31	glutamate receptor, ionotropic, kainate 3	Mus musculus	61-67
25881041-10	2015	In addition, both MMPIP and PPG acted as inverse agonists at mGluR7, and agonists at mGluR8.	ppg	28-31	glutamate receptor, metabotropic 8	Mus musculus	85-91
25066229-2	2015	The relative contribution of postprandial plasma glucose (PPG) to overall HbA1c is estimated at 40-60%, with the effect of PPG on HbA1c being prominent in patients on basal insulin.	ppg	58-61	hemoglobin subunit alpha 1	Homo sapiens	74-78
25066229-2	2015	The relative contribution of postprandial plasma glucose (PPG) to overall HbA1c is estimated at 40-60%, with the effect of PPG on HbA1c being prominent in patients on basal insulin.	ppg	123-126	insulin	Homo sapiens	173-180
26428031-5	2015	Prandial GLP-1 RAs have a short plasma half-life and are particularly effective at targeting PPG elevations, whereas long-acting non-prandial GLP-1 RAs are more effective at reducing fasting plasma glucose.	ppg	93-96	glucagon like peptide 1 receptor	Homo sapiens	9-14
25050128-2	2014	TFR (11~2700 mg/L) evoked dose-dependent vasodilation and hyperpolarization in MCA of both sham and CIR that were partially inhibited by 30 muM N-nitro-L-arginine-methyl-ester and 10 muM indomethacin and further attenuated by endogenous H2S synthese-CSE inhibitor PPG (100 muM) or Ca(2+)-activated potassium channel (Kca) inhibitor TEA (1 mM).	ppg	264-267	transferrin receptor	Rattus norvegicus	0-3
24641271-2	2014	This meta-analysis aimed to investigate the effects of the once-daily prandial GLP-1 receptor agonist lixisenatide on postprandial plasma glucose (PPG), glucagon and insulin levels.	ppg	147-150	glucagon like peptide 1 receptor	Homo sapiens	79-93
24926379-7	2014	The combination therapy of vildagliptin plus an alpha-glucosidase inhibitor effectively reduced the FBG, PPG and HbA1c levels in patients without inducing weight gain or hepatorenal dysfunction.	ppg	105-108	sucrase-isomaltase	Homo sapiens	48-65
23992745-2	2014	GLP-1 delays gastric emptying, which is vital for postprandial glucose (PPG) control.	ppg	72-75	glucagon	Homo sapiens	0-5
29922357-5	2013	Glucagon-like peptide 1 (GLP-1) receptor agonists have shown substantial efficacy in improving overall glycaemic control but have differing effects on PPG, which is a result of their different mechanisms of action.	ppg	151-154	glucagon	Homo sapiens	0-23
24147558-4	2013	In patients with moderate hyperglycemia, PPG excursions have a greater contribution to overall hyperglycemia, with this contribution being greatest when HbA1c is approximately 7-8% [1] .	ppg	41-44	hemoglobin subunit alpha 1	Homo sapiens	153-157
29922357-5	2013	Glucagon-like peptide 1 (GLP-1) receptor agonists have shown substantial efficacy in improving overall glycaemic control but have differing effects on PPG, which is a result of their different mechanisms of action.	ppg	151-154	glucagon like peptide 1 receptor	Homo sapiens	25-40
23864951-7	2013	Interestingly, inhibiting endogenous, CSE-dependent H2S production with PPG did not exacerbate the deleterious vascular changes seen in the untreated fat-fed ApoE(-/-) mice.	ppg	72-75	cystathionase (cystathionine gamma-lyase)	Mus musculus	38-41
23448112-4	2013	However, evidence supporting the cost-effectiveness of PPG-CSF is inconclusive, and American Society of Clinical Oncology guidelines state the need for performing cost analyses in high-risk groups like the elderly.	ppg	55-58	colony stimulating factor 2	Homo sapiens	59-62
23448112-5	2013	OBJECTIVES: To examine the effect of PPG-CSF administration on neutropenia hospitalization costs and overall Medicare costs during the year following chemotherapy initiation.	ppg	37-40	colony stimulating factor 2	Homo sapiens	41-44
23448112-10	2013	CONCLUSIONS: A significant part of the increase in immediate medical costs in breast cancer patients receiving PPG-CSF is due to improved chemotherapy administration.	ppg	111-114	colony stimulating factor 2	Homo sapiens	115-118
23527297-7	2013	Furthermore, the enhanced therapeutic efficacy of PPG could be correlated with effective silencing of miR-21 and with increased accumulation of ADR in drug-resistant tumor cells.	ppg	50-53	microRNA 21	Homo sapiens	102-108
22836490-6	2012	Lastly, SgI(O) ([mg/dl]/min) was calculated as [PPG-without insulin and Sg]-[PPG-without insulin / with Sg] x [(2hPG) / 2hPG(E)].	ppg	48-51	semenogelin 1	Homo sapiens	8-11
22836490-6	2012	Lastly, SgI(O) ([mg/dl]/min) was calculated as [PPG-without insulin and Sg]-[PPG-without insulin / with Sg] x [(2hPG) / 2hPG(E)].	ppg	77-80	semenogelin 1	Homo sapiens	8-11
22436069-8	2012	At lower/near normal HbA(1C) , a short-acting GLP-1 RA, such as exenatide twice-daily, may be a better choice as its effects are more pronounced with PPG.	ppg	150-153	glucagon like peptide 1 receptor	Homo sapiens	46-51
22074719-7	2012	Both aspartate, which inhibits the 3-MST synthesis pathway, and propargylglycine (PPG), which inhibits the CSE pathway, significantly reduced the increases in arterial pressure during hypoxia.	ppg	82-85	cystathionine gamma-lyase	Rattus norvegicus	107-110